• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人II型精氨酸酶的表达、纯化及特性分析

Expression, purification, and characterization of human type II arginase.

作者信息

Colleluori D M, Morris S M, Ash D E

机构信息

Temple University School of Medicine, Department of Biochemistry, Philadelphia, Pennsylvania 19140, USA.

出版信息

Arch Biochem Biophys. 2001 May 1;389(1):135-43. doi: 10.1006/abbi.2001.2324.

DOI:10.1006/abbi.2001.2324
PMID:11370664
Abstract

Human type II arginase, which is extrahepatic and mitochondrial in location, catalyzes the hydrolysis of arginine to form ornithine and urea. While type I arginases function in the net production of urea for excretion of excess nitrogen, type II arginases are believed to function primarily in the net production of ornithine, a precursor of polyamines, glutamate, and proline. Type II arginases may also regulate nitric oxide biosynthesis by modulating arginine availability for nitric oxide synthase. Recombinant human type II arginase was expressed in Escherichia coli and purified to apparent homogeneity. The Km of arginine for type II arginase is approximately 4.8 mM at physiological pH. Type II arginase exists primarily as a trimer, although higher order oligomers were observed. Borate is a noncompetitive inhibitor of the enzyme, with a Kis of 0.32 mM and a Kii of 0.3 mM. Ornithine, a product of the reaction catalyzed by arginase and a potent inhibitor of type I arginase, is a poor inhibitor of the type II isozyme. The findings presented here indicate that isozyme-selectivity exists between type I and type II arginases for binding of substrate and products, as well as inhibitors. Therefore, inhibitors with greater isozyme-selectivity for type II arginase may be identified and utilized for the therapeutic treatment of smooth muscle disorders, such as erectile dysfunction.

摘要

人II型精氨酸酶位于肝外且存在于线粒体中,催化精氨酸水解生成鸟氨酸和尿素。I型精氨酸酶的作用是净生成尿素以排泄多余的氮,而II型精氨酸酶据信主要作用是净生成鸟氨酸,鸟氨酸是多胺、谷氨酸和脯氨酸的前体。II型精氨酸酶还可能通过调节一氧化氮合酶可利用的精氨酸来调控一氧化氮的生物合成。重组人II型精氨酸酶在大肠杆菌中表达并纯化至表观均一。在生理pH条件下,II型精氨酸酶对精氨酸的Km约为4.8 mM。II型精氨酸酶主要以三聚体形式存在,不过也观察到了更高阶的寡聚体。硼酸盐是该酶的非竞争性抑制剂,其Kis为0.32 mM,Kii为0.3 mM。鸟氨酸是精氨酸酶催化反应的产物,也是I型精氨酸酶的强效抑制剂,但对II型同工酶的抑制作用较弱。此处呈现的研究结果表明,I型和II型精氨酸酶在底物、产物以及抑制剂的结合方面存在同工酶选择性。因此,或许可以鉴定出对II型精氨酸酶具有更高同工酶选择性的抑制剂,并将其用于治疗平滑肌疾病,如勃起功能障碍。

相似文献

1
Expression, purification, and characterization of human type II arginase.人II型精氨酸酶的表达、纯化及特性分析
Arch Biochem Biophys. 2001 May 1;389(1):135-43. doi: 10.1006/abbi.2001.2324.
2
Classical and slow-binding inhibitors of human type II arginase.人II型精氨酸酶的经典和慢结合抑制剂。
Biochemistry. 2001 Aug 7;40(31):9356-62. doi: 10.1021/bi010783g.
3
L-arginine binding to liver arginase requires proton transfer to gateway residue His141 and coordination of the guanidinium group to the dimanganese(II,II) center.L-精氨酸与肝脏精氨酸酶的结合需要质子转移至门户残基His141,并使胍基与二锰(II,II)中心配位。
Biochemistry. 1998 Jun 9;37(23):8539-50. doi: 10.1021/bi972874c.
4
In hepatocytes the regulation of NOS-2 activity at physiological L-arginine levels suggests a close link to the urea cycle.在肝细胞中,生理水平的L-精氨酸对一氧化氮合酶2(NOS-2)活性的调节表明其与尿素循环密切相关。
Nitric Oxide. 2006 Jun;14(4):300-8. doi: 10.1016/j.niox.2005.11.009. Epub 2006 Jan 10.
5
Biochemical studies on Helicobacter pylori arginase: insight into the difference in activity compared to other arginases.幽门螺杆菌精氨酸酶的生化研究:对其与其他精氨酸酶活性差异的深入了解。
IUBMB Life. 2010 Dec;62(12):906-15. doi: 10.1002/iub.401.
6
Expression of human liver arginase in Escherichia coli. Purification and properties of the product.人肝脏精氨酸酶在大肠杆菌中的表达。产物的纯化及性质
Biochem J. 1990 Sep 15;270(3):697-703. doi: 10.1042/bj2700697.
7
Urea cycle of Fasciola gigantica: purification and characterization of arginase.巨大片吸虫的尿素循环:精氨酸酶的纯化与特性分析
Comp Biochem Physiol B Biochem Mol Biol. 2005 Nov;142(3):308-16. doi: 10.1016/j.cbpb.2005.08.002. Epub 2005 Aug 26.
8
Human arginase II: crystal structure and physiological role in male and female sexual arousal.人类精氨酸酶II:晶体结构及在男性和女性性唤起中的生理作用。
Biochemistry. 2003 Jul 22;42(28):8445-51. doi: 10.1021/bi034340j.
9
Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily.幽门螺杆菌精氨酸酶RocF的纯化与特性:精氨酸酶超家族中的独特特征
Eur J Biochem. 2004 May;271(10):1952-62. doi: 10.1111/j.1432-1033.2004.04105.x.
10
Arginase: structure, mechanism, and physiological role in male and female sexual arousal.精氨酸酶:在男性和女性性唤起中的结构、机制及生理作用
Acc Chem Res. 2005 Mar;38(3):191-201. doi: 10.1021/ar040183k.

引用本文的文献

1
Divergent roles of red cell arginase in humans and mice: RBC Arg1 KO mice show preserved systemic l-arginine bioavailability and infarct size in vivo.红细胞精氨酸酶在人类和小鼠中的不同作用:红细胞精氨酸酶1基因敲除(RBC Arg1 KO)小鼠在体内表现出系统中L-精氨酸生物利用度和梗死面积保持不变。
Redox Biol. 2025 Jul 14;86:103768. doi: 10.1016/j.redox.2025.103768.
2
The roles of arginases and arginine in immunity.精氨酸酶和精氨酸在免疫中的作用。
Nat Rev Immunol. 2025 Apr;25(4):266-284. doi: 10.1038/s41577-024-01098-2. Epub 2024 Oct 17.
3
Role of Arginase-II in Podocyte Injury under Hypoxic Conditions.
缺氧条件下诱导型一氧化氮合酶在足细胞损伤中的作用。
Biomolecules. 2022 Aug 31;12(9):1213. doi: 10.3390/biom12091213.
4
Homoarginine and inhibition of human arginase activity: kinetic characterization and biological relevance.精氨酸同型物和人精氨酸酶活性的抑制作用:动力学特征和生物学相关性。
Sci Rep. 2018 Feb 27;8(1):3697. doi: 10.1038/s41598-018-22099-x.
5
Labile Low-Molecular-Mass Metal Complexes in Mitochondria: Trials and Tribulations of a Burgeoning Field.线粒体中不稳定的低分子量金属络合物:一个新兴领域的试验与磨难
Biochemistry. 2016 Aug 2;55(30):4140-53. doi: 10.1021/acs.biochem.6b00216. Epub 2016 Jul 19.
6
Crystal structure of Schistosoma mansoni arginase, a potential drug target for the treatment of schistosomiasis.曼氏血吸虫精氨酸酶的晶体结构,一种治疗血吸虫病的潜在药物靶点。
Biochemistry. 2014 Jul 22;53(28):4671-84. doi: 10.1021/bi5004519. Epub 2014 Jul 9.
7
Modulation of Asthma Pathogenesis by Nitric Oxide Pathways and Therapeutic Opportunities.一氧化氮途径对哮喘发病机制的调节及治疗机会
Drug Discov Today Dis Mech. 2012 Dec 1;9(3-4):e89-e94. doi: 10.1016/j.ddmec.2012.10.004.
8
Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.氧化应激对冠状动脉微循环的血管运动调节:精氨酸酶的作用。
Front Immunol. 2013 Aug 19;4:237. doi: 10.3389/fimmu.2013.00237. eCollection 2013.
9
Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation.精氨酸酶:血管氧化应激和炎症的新兴治疗靶点。
Front Immunol. 2013 Jun 12;4:149. doi: 10.3389/fimmu.2013.00149. eCollection 2013.
10
Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.优化工程化人精氨酸酶 I 用于癌症治疗的血清半衰期的策略。
J Control Release. 2012 Feb 28;158(1):171-9. doi: 10.1016/j.jconrel.2011.09.097. Epub 2011 Oct 6.